Spatiotemporal depletion of tumor-associated immune checkpoint PD-L1 with near-infrared photoimmunotherapy promotes antitumor immunity

Código QR

Spatiotemporal depletion of tumor-associated immune checkpoint PD-L1 with near-infrared photoimmunotherapy promotes antitumor immunity

Guardado en:

Detalles Bibliográficos
Autores principales:	Shunichi Taki, Kohei Matsuoka, Yuko Nishinaga, Kazuomi Takahashi, Hirotoshi Yasui, Chiaki Koike, Misae Shimizu, Mitsuo Sato, Kazuhide Sato
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/6fce37aff25441e788d1e7a7cc1e0694
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Association between inflammatory cytokines and immune-checkpoint molecule in rheumatoid arthritis.
por: Haruki Matsumoto, et al.
Publicado: (2021)

Association between inflammatory cytokines and immune–checkpoint molecule in rheumatoid arthritis
por: Haruki Matsumoto, et al.
Publicado: (2021)

Immune checkpoint inhibitor combination therapies very frequently induce secondary adrenal insufficiency
por: Katsunori Manaka, et al.
Publicado: (2021)

Enhancing mucosal immunity by transient microbiota depletion
por: Simone Becattini, et al.
Publicado: (2020)

Indicators of responsiveness to immune checkpoint inhibitors
por: Bradley D. Shields, et al.
Publicado: (2017)

Fibroblast activation protein targeted near infrared photoimmunotherapy (NIR PIT) overcomes therapeutic resistance in human esophageal cancer
por: Ryoichi Katsube, et al.
Publicado: (2021)

Managing cardiotoxicity associated with immune checkpoint inhibitors
por: Sireesha Upadhrasta, et al.
Publicado: (2019)

The roles of exosomal immune checkpoint proteins in tumors
por: Cheng Xing, et al.
Publicado: (2021)

CANCER IMMUNOTHERAPY BASED ON THE BLOCKADE OF IMMUNE CHECKPOINTS
por: A. V. Bogolyubova, et al.
Publicado: (2015)

Immune-mediated adverse events in immune checkpoint inhibitors therapy: literature review
por: Marina A. Lyadova, et al.
Publicado: (2021)

Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma
por: Shawn T. Beug, et al.
Publicado: (2017)

Cardiac MRI in Immune Checkpoint Inhibitor Associated Pericarditis
por: Can Öztürk, et al.
Publicado: (2021)

Evaluating the impact of age on immune checkpoint therapy biomarkers
por: Rossin Erbe, et al.
Publicado: (2021)

Metabolomic adaptations and correlates of survival to immune checkpoint blockade
por: Haoxin Li, et al.
Publicado: (2019)

A decade of immune-checkpoint inhibitors in cancer therapy
por: Caroline Robert
Publicado: (2020)

Predictors of responses to immune checkpoint blockade in advanced melanoma
por: N. Jacquelot, et al.
Publicado: (2017)

Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints
por: Yaolin Xu, et al.
Publicado: (2021)

Spatiotemporal dynamics of a glioma immune interaction model
por: Subhas Khajanchi, et al.
Publicado: (2021)

CD96, a new immune checkpoint, correlates with immune profile and clinical outcome of glioma
por: Fangkun Liu, et al.
Publicado: (2020)

Myocarditis Induced by Immune Checkpoint Inhibitors: Mechanisms and Therapeutic Prospects
por: Zou W, et al.
Publicado: (2021)

Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors
por: Nicola Personeni, et al.
Publicado: (2021)

Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas
por: Katrin Aslan, et al.
Publicado: (2020)

Immune checkpoint modulation enhances HIV-1 antibody induction
por: Todd Bradley, et al.
Publicado: (2020)

Management of gastrointestinal adverse events induced by immune-checkpoint inhibitors
por: Zheng-Hang Wang, et al.
Publicado: (2018)

Acute kidney injury in patients treated with immune checkpoint inhibitors
por: Enriqueta Felip, et al.
Publicado: (2021)

Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
por: Kennedy Yao Yi Ng, et al.
Publicado: (2021)

Association of blood biomarkers and autoimmunity with immune related adverse events in patients with cancer treated with immune checkpoint inhibitors
por: Despina Michailidou, et al.
Publicado: (2021)

Correction: Publisher Correction: Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma
por: Shawn T. Beug, et al.
Publicado: (2018)

Combination of Near-Infrared Photoimmunotherapy Using Trastuzumab and Small Protein Mimetic for HER2-Positive Breast Cancer
por: Haruka Yamaguchi, et al.
Publicado: (2021)

Immune checkpoint molecule expression is altered in the skin and peripheral blood in vasculitis
por: Chie Miyabe, et al.
Publicado: (2021)

Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer
por: Jun Zhao, et al.
Publicado: (2019)

Adverse Effects and Toxicity of Immune Checkpoint Inhibitors For Patients With Urothelial Carcinoma
por: Di Wang, et al.
Publicado: (2021)

Cure the Incurable? Recent Breakthroughs in Immune Checkpoint Blockade for Hepatocellular Carcinoma
por: Pei-Yi Chu, et al.
Publicado: (2021)

Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy
por: Andrew Haydon, et al.
Publicado: (2021)

Neoadjuvant immune checkpoint inhibitor plus chemotherapy in rare tracheal tumors
por: Ben‐Yuan Jiang, et al.
Publicado: (2021)

Cutaneous Adverse Events of Immune Checkpoint Inhibitors: A Literature Review
por: Zoe Apalla, et al.
Publicado: (2021)

Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution
por: Mirjana Efremova, et al.
Publicado: (2018)

Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases
por: Xin Cai, et al.
Publicado: (2021)

Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers
por: Yingyan Yu
Publicado: (2021)

Progress of Immune Checkpoint Inhibitors  in the Treatment of Advanced Pulmonary Neuroendocrine Tumors
por: Haoqing CHEN, et al.
Publicado: (2021)